Clinical investigation of cervical disc lesion without spondylosis.
スポンサーリンク
概要
- 論文の詳細を見る
From 1977 through 1983, 71 patients were operated on at our hospital. They did not have spondylotic changes, that is, posterior spur formation, narrow foramen or deformities of the Luschka joints. These 71 cases, which included 36 cases with discogenic myelopathy, 31 with discogenic radiculopathy and 4 with local signs, were followed up.Results were as follows:1) Age of onset was 40 years on the average, and that was 15 years younger than that of 111 patients with CSM and CSR who underwent surgery at our hospital.2) The provocative rate was about 33 percent. Traumatic factors were: traffic accidents (7 cases), degradation accidents (5 cases), falling down (4 cases), contusion (2 cases) and sports injuries (1 case).3) The frequencies of the lesion levels were, in order: C5/6 (54.4%), C4/5 (24.8%), C6/7 (14.9%), C3/4 (5.0%) and C7/Th1 (1.0%). This tends to be the same as for cervical spondylotic myelopathy and radiculopathy.4) Narrow disc (56%), instability (54%), retrolisthesis (32%), angulation (22%) on the plain X-P were diagnostic changes of the cervical disc lesion. Clinical signs of these lesions were inclined to occur in the cases that were accompanied by narrow canal and anterior shift of the upper apex in the superior facet.5) Myelography was very valuable as a diagnostic technique to determine the main foous, especially in cases with spondylosis on other levels.6) Operation procedures were Cloward's method (38 cases), Simmons (31 cases) and Smith-Robinson (2 cases). The results of all were excellent. 24 cases (85.7%) of the 28 patients with myelopathy who could be followed up had more than 16 points using JOA standard of CSM.
- 西日本整形・災害外科学会の論文
著者
関連論文
- 医師不足調査よりみた整形外科医療環境の現状について (第21回日本臨床整形外科学会学術集会)
- 413. 腰部椎間板症に対する腰椎前方椎体固定術の術後理学療法および術後成績
- 73. Lifting動作の三次元的解析 : Lumbar Motion MonitorとEMGを用いての意識の有無による腰椎変化の検討
- 椎間板のバイオメカニクスから見た運動療法 : X線学的分析を中心に
- 整形外科におけるリスクマネジメント (特集 整形外科で起こりやすい医療事故とその対策)
- 活性型プロテインC(APC)は白血球の活性化を抑制することで実験的脊髄損傷後の運動麻痺を著明に軽減する
- 9.メシル酸ガベキサート(FOY)は実験的脊髄損傷後の運動麻痺を著明に改善する : その抗凝固以外の新しい作用について(脊髄損傷-治療II)
- アンチトロンビンIII(ATIII)は白血球の活性化を抑制することで実験的脊髄損傷後の運動麻痺を著明に軽減する
- メシル酸ガベキサート(FOY)は実験的脊髄損傷後の運動麻痺を著明に改善する ; その抗凝固以外の新しい作用について
- リコンビナントトロンボモジュリン(r-TM)はプロテインCを活性化することで実験的脊髄損傷後の運動麻痺を著明に軽減する